Methyl 2-methyl-3-nitrobenzoate: A Key Intermediate in Lenalidomide Synthesis and Pharmaceutical Research
Discover the critical role of Methyl 2-methyl-3-nitrobenzoate in advancing pharmaceutical synthesis and medicinal chemistry.
Get a Quote & SampleProduct Core Value
Methyl 2-methyl-3-nitrobenzoate
Methyl 2-methyl-3-nitrobenzoate, identified by CAS number 59382-59-1, is a vital organic compound extensively utilized as a precursor in the synthesis of the important anticancer drug Lenalidomide. Its chemical structure and properties make it an indispensable building block in medicinal chemistry, enabling the creation of complex molecular architectures essential for pharmaceutical development.
- This key intermediate plays a vital role in Lenalidomide synthesis, contributing to the production of life-saving anticancer therapies.
- As a versatile organic synthesis building block, it facilitates the creation of diverse organic compounds for various research applications.
- The compound is recognized as a significant pharmaceutical intermediate with CAS 59382-59-1, underscoring its importance in the regulated pharmaceutical industry.
- Its application as an anticancer drug precursor highlights its direct contribution to therapeutic advancements in oncology.
Advantages Offered
High Purity for Research
With guaranteed purity, Methyl 2-methyl-3-nitrobenzoate ensures reliable results in complex synthetic pathways, supporting accurate medicinal chemistry building block applications.
Versatile Synthetic Applications
This compound serves as a fundamental component for synthesizing various complex organic molecules, making it a cornerstone for researchers exploring new therapeutic agents.
Contribution to Cancer Treatment
Its role in the Lenalidomide synthesis intermediate chain directly impacts the availability of critical treatments for specific cancers.
Key Applications
Lenalidomide Synthesis
A primary application is its use as a critical precursor in the multi-step synthesis of Lenalidomide, an immunomodulatory drug used to treat multiple myeloma and other conditions.
Pharmaceutical Research
Serves as a valuable intermediate for the development of novel pharmaceutical compounds, facilitating research into new drug candidates and therapeutic pathways.
Organic Synthesis
Its reactive functional groups make it a versatile tool for organic chemists, enabling the construction of diverse molecular structures.
Medicinal Chemistry
Integral to drug discovery efforts, it acts as a fundamental building block for creating libraries of compounds to screen for biological activity.
Related Technical Articles & Resources
Why Choose Us?
Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.
Global Experience
With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.
Advanced Facilities
Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.
Seamless Scalability
We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).